Stay updated on Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected; core study information (title, purpose, eligibility, endpoints) and the page’s primary functions remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:32:25.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a new medical term; - Updated version from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-05T10:32:53.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Update: version bumped from v3.0.2 to v3.1.0, indicating a new release. No other content changes are indicated.
    Difference
    0.1%
    Check dated 2025-09-28T03:21:56.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the old revision label was removed. The 'Back to Top' element was also removed, which is a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-13T17:43:50.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, v3.0.1, indicating a recent revision. The previous update information has been removed.
    Difference
    0.2%
    Check dated 2025-09-06T15:30:02.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The web page has added a facility name and location details, including specific dates related to recurrent respiratory papillomatosis and pembrolizumab, while removing various location terms and previous dates.
    Difference
    4%
    Check dated 2025-08-30T12:16:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.